Analysis of Local Treatment-emergent Adverse Events in Patients With CIDP Treated With fSCIG During the ADVANCE-CIDP1 and Long-term ADVANCE-CIDP3 Trials

Measuring Disease Activity During Maintenance Therapy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Serum NfL Z-score as a Biomarker of Disease Severity and Treatment History in the Largest CIDP Cohort to Date: Insights from the ADHERE Trial